Skip to main content

Phase 1 Multicenter, Open-Label, Dose-Escalation, Combination Study of Marizomib and Bevacizumab-Naive Subjects with Grade IV Malignant Glioma

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Celgene Research and Development

Start Date

April 1, 2015

End Date

September 22, 2021
 

Administered By

Duke Cancer Institute

Awarded By

Celgene Research and Development

Start Date

April 1, 2015

End Date

September 22, 2021